Patients undergoing elective laparoscopic colorectal surgery
Conditions
Interventions
Patients assigned to the non-Oral group received 1 g of cefmetazole intravenously 30 min before the skin incision, then every 3 h during and immediately after the operation, stopping 24 h after comple
Sponsors
Cancer Institute Hospital of Japanese Foundation for Cancer Research, Department of Gastroenterological surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing elective laparoscopic colorectal surgery Patients who inderstand the study and agre with written informed consent.
Exclusion criteria
Exclusion criteria: 1)ileus 2)synchronous resection of other major organs 3)Patients who need antibiotics for other infectious diseases. 4)Patients who have undergone antibiotic administration 2 weeks before the surgery. 5)Patients with severe liver dysfunction 6)Patients with severe renal impairment 7)Patients with severe cardiac dysfunction 8)Patients with severe pulmonary dysfunction 9)Pregnancy or suspicion of pregnancy 10)lactating women 11)Patients who are considered unsuitable for the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the incidence of overall surgical site infection. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints are the incidence of incisional site infections, organ/space infections, and enterocolitis. | — |
Countries
Japan
Contacts
Public ContactKonishi Tsuyoshi
Cancer Institute Hospital of Japanese Foundation for Cancer Research Department of Gastroenterological surgery
Outcome results
None listed